Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double-Blind, Placebo-Controlled Phase II Trial.
Lee O, Pilewskie M, Karlan S, Tull MB, Benante K, Xu Y, Blanco L, Helenowski I, Kocherginsky M, Yadav S, Hosseini O, Hansen N, Bethke K, Muzzio M, Troester MA, Dimond E, Perloff M, Heckman-Stoddard B, Khan SA. Lee O, et al. Among authors: yadav s. Clin Pharmacol Ther. 2021 Mar;109(3):728-738. doi: 10.1002/cpt.2041. Epub 2020 Oct 25. Clin Pharmacol Ther. 2021. PMID: 32996592 Free PMC article. Clinical Trial.
Author Correction: Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer.
Yadav S, Virk R, Chung CH, Eduardo MB, VanDerway D, Chen D, Burdett K, Gao H, Zeng Z, Ranjan M, Cottone G, Xuei X, Chandrasekaran S, Backman V, Chatterton R, Khan SA, Clare SE. Yadav S, et al. NPJ Breast Cancer. 2023 Mar 13;9(1):11. doi: 10.1038/s41523-023-00516-3. NPJ Breast Cancer. 2023. PMID: 36914690 Free PMC article. No abstract available.
Augmenting trauma-focused cognitive behavior therapy for post-traumatic stress disorder with memory specificity training: a randomized controlled trial.
Bryant RA, Dawson KS, Yadav S, Tran J, Choi-Christou J, Rawson N, Tockar J, Stech E, Garber B, Broomfield C, Harrison A, Keyan D, Azevedo S. Bryant RA, et al. Among authors: yadav s. World Psychiatry. 2025 Feb;24(1):113-119. doi: 10.1002/wps.21280. World Psychiatry. 2025. PMID: 39810665 Free PMC article.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau HS, Carter LM, Lee EHC, Lam HY, Okina E, Tan DJJ, Tan W, Ang HL, Carbone D, Yee MY, Shanmugam MK, Huang XZ, Sethi G, Tan TZ, Lim LHK, Huang RY, Ungefroren H, Giovannetti E, Tang DG, Bruno TC, Luo P, Andersen MH, Qian BZ, Ishihara J, Radisky DC, Elias S, Yadav S, Kim M, Robert C, Diana P, Schalper KA, Shi T, Merghoub T, Krebs S, Kusumbe AP, Davids MS, Brown JR, Kumar AP. Glaviano A, et al. Among authors: yadav s. J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6. J Hematol Oncol. 2025. PMID: 39806516 Free PMC article. Review.
Advancing siRNA Therapeutics targeting MCT-4: A Multifaceted approach integrating Arithmetical Designing, Screening, and molecular dynamics validation.
Pandey AR, Kumar A, Shrivastava NK, Singh J, Yadav S, Sonkar AB, Kumar D, Kumar R, Saeedan AS, Ansari MN, Aldossary SA, Akhter Y, Kaithwas G. Pandey AR, et al. Among authors: yadav s. Int Immunopharmacol. 2025 Jan 10;147:113980. doi: 10.1016/j.intimp.2024.113980. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39798472
5,236 results